Yakira Capital Management, Inc. - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 20 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Yakira Capital Management, Inc. ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$10,000
-47.4%
127,4970.0%0.00%
-33.3%
Q1 2022$19,000
-48.6%
127,4970.0%0.00%
-40.0%
Q4 2021$37,000
-65.7%
127,497
-11.5%
0.01%
-70.6%
Q3 2021$108,000–144,097–0.02%–
 Download
Other shareholders
CLARUS THERAPEUTICS HLDNGS I shareholders Q2 2022
NameSharesValueWeighting ↓
LMR Partners LLP 229,750$342,0000.00%
Yakira Capital Management, Inc. 127,497$19,0000.00%
Bulldog Investors, LLP 42,601$6,0000.00%
CVI Holdings, LLC 247,578$36,0000.00%
ARISTEIA CAPITAL, L.L.C. 223,135$34,0000.00%
Context Capital Management, LLC 62,175$9,0000.00%
MARSHALL WACE, LLP 250,000$373,0000.00%
MIZUHO SECURITIES USA LLC 25,000$4,0000.00%
Tower Research Capital LLC (TRC) 91$00.00%
Virtu Financial LLC 13,479$2,0000.00%
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders